2141-V11 is an anti-CD40 agonist antibody that is enhanced by binding to FcγRIIB. In vivo, 2141-V11 can initiate an effective tumor-specific T-cell response and is applicable in the study of BCG-unresponsive non-muscle-invasive bladder cancer.
2141-V11
2141-V11
😃Good
Catalog No. T9901A-1567Cas No. 2923542-55-4
2141-V11 is an anti-CD40 agonist antibody that is enhanced by binding to FcγRIIB. In vivo, 2141-V11 can initiate an effective tumor-specific T-cell response and is applicable in the study of BCG-unresponsive non-muscle-invasive bladder cancer.
Pack Size
Price
USA Warehouse
Global Warehouse
Quantity
1 mg
Inquiry
Inquiry
Inquiry
5 mg
Inquiry
Inquiry
Inquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
2141-V11 is an anti-CD40 agonist antibody that is enhanced by binding to FcγRIIB. In vivo, 2141-V11 can initiate an effective tumor-specific T-cell response and is applicable in the study of BCG-unresponsive non-muscle-invasive bladder cancer.
Chemical Properties
Cas No.
2923542-55-4
Storage & Solubility Information
Storage
store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.
Calculator
Dilution Calculator
Reconstitution Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy 2141-V11 | purchase 2141-V11 | 2141-V11 cost | order 2141-V11